Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
June 7th, 2019
8K views
A procedure is presented to visualize protein kinase A activities in head-fixed, behaving mice. An improved A-kinase activity reporter, tAKARα, is expressed in cortical neurons and made accessible for imaging through a cranial window. Two-photon fluorescence lifetime imaging microscopy is used to visualize PKA activities in vivo during enforced locomotion.
Our method utilizes a novel protein kinase A sensor called target A kinase activity reporter alpha, or tAKAR
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a procedure for visualizing protein kinase A (PKA) activity in head-fixed, behaving mice using an improved PKA activity reporter, tAKARα. The reporter is expressed in cortical neurons and allows imaging through a cranial window using two-photon fluorescence lifetime imaging microscopy during locomotion.
Key Study Components
Area of Science
- Neuroscience
- Imaging techniques
- Protein kinase signaling
Background
- Protein kinase A plays a crucial role in neuronal signaling and plasticity.
- Understanding PKA activity in vivo can reveal insights into behavioral mechanisms.
- Head-fixed mice allow for the observation of behaviors while controlling for external variables.
- Previous imaging methods have limitations that this study aims to overcome.
Purpose of Study
- To visualize PKA activity in behaving mice during locomotion.
- To utilize an advanced imaging technique to gain insights into brain signaling dynamics.
- To improve upon existing methods of visualizing kinase activities in live animals.
Methods Used
- Utilization of two-photon fluorescence lifetime imaging microscopy as the main imaging platform.
- The key biological model involves expressing the tAKARα reporter in cortical neurons of head-fixed mice.
- Mice are subjected to enforced locomotion to study changes in PKA activity.
- Imaging is conducted through a cranial window to allow real-time observations.
Main Results
- The study successfully visualizes and monitors PKA activity in vivo, demonstrating dynamic cellular signaling during behavior.
- Observed changes in PKA activity correlate with locomotion, highlighting the mechanistic role of PKA in behavior.
- Results indicate significant methodological improvements over previous imaging techniques.
Conclusions
- This study demonstrates a novel approach to visualize PKA activity, enabling better understanding of neuronal signaling during behavior.
- The findings have implications for future research on neuronal mechanisms and plasticity.
- Overall, the methodological advancements presented could enhance studies in behavioral neuroscience.
Frequently Asked Questions
What are the advantages of using head-fixed mice for PKA imaging?
Head-fixed mice allow precise control of experimental conditions while enabling the study of neuronal activity during naturalistic behaviors such as locomotion.
How is the tAKARα reporter expressed in the mice?
The tAKARα reporter is expressed in cortical neurons, enabling real-time imaging of PKA activities during behavioral tasks.
What types of data can be obtained from this imaging method?
The method provides data on PKA activity dynamics, allowing researchers to correlate kinase activity with specific behaviors and neuronal responses.
Can this method be adapted for other types of kinase imaging?
Yes, the imaging technique and reporter design could be modified to study different kinases, expanding its application to various signaling pathways in neuroscience.
What are the limitations of this imaging method?
Limitations may include potential interference from other cellular signaling pathways and the need for surgical procedures to implant cranial windows.
How does two-photon fluorescence lifetime imaging microscopy improve observations?
Two-photon microscopy offers deeper tissue penetration and less photodamage, allowing for detailed imaging of dynamic cellular processes in vivo.
What implications do the findings have for behavioral neuroscience?
The findings provide insights into the role of PKA in neuronal signaling during behavior, potentially influencing future research on learning and memory mechanisms.
Executive Industry Relevance
Visualizing intracellular signaling dynamics in behaving animals bridges the gap between molecular mechanisms and behavioral phenotypes, a critical step in target validation for CNS drug discovery. This method enables real-time, single-cell resolution monitoring of PKA activity—a convergent node for multiple neuromodulatory pathways—during defined behaviors, providing mechanistic de-risking for targets upstream of cAMP signaling. By correlating kinase activity with locomotion in head-fixed mice, the approach supports predictive confidence in target engagement and pathway modulation, informing early go/no-go decisions in neuropsychiatric drug programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by visualizing PKA activity as a readout for neuromodulatory GPCR signaling in defined neuronal populations.
- Operational Value: Enables functional target validation in intact neural circuits during behavior, reducing mechanistic ambiguity in target selection.
- Predictive Value: Supports portfolio triage by linking target modulation to measurable changes in kinase activity during relevant behavioral states.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems (cortical neurons expressing tAKARα) for downstream compound screening against neuromodulatory targets.
- Quantitative Output: Provides FRET-based FLIM readouts that enable standardized, reproducible measurement of PKA activity changes in response to pharmacological perturbations.
- Scalability: The chronic cranial window and head-fixed preparation allow repeated imaging sessions, supporting longitudinal assessment of compound effects on signaling dynamics.
Translational & Preclinical Research
- Disease Relevance: Applicable to studying PKA dysregulation in models of neuropsychiatric disorders where neuromodulatory signaling is impaired.
- Translational Continuity: Bridges discovery-phase target validation with preclinical efficacy testing by maintaining consistent readout of pathway activity across stages.
- Risk-Adjusted Advancement: Enables early assessment of whether candidate compounds engage targets and modulate downstream signaling in behaving animals, informing dose selection and mechanism-based biomarkers.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing through lead identification to preclinical validation, offering a mechanistic readout that informs progression decisions at each stage.
- Discovery Biology: Supports hypothesis testing by visualizing PKA activity changes in response to neuromodulator release or receptor manipulation during behavior.
- Screening: Enables assay readiness for evaluating compound effects on cAMP/PKA signaling in neuronal networks with cellular resolution.
- Analytics: Generates quantitative FLIM-based FRET measurements that allow comparison of signaling dynamics across conditions, genotypes, or treatments.
- Translational Research: Connects to preclinical work by providing a translatable readout of pathway engagement that can be mirrored in biomarker strategies.
- Enterprise Reuse: Establishes a reusable platform for studying multiple neuromodulatory targets converging on PKA, applicable across brain regions and behavioral paradigms.
Operational & Enterprise Impact
- Scientific Value: Delivers predictive confidence in target mechanism by directly visualizing kinase activity as a functional readout of pathway modulation.
- Operational Value: Standardizes measurement of intracellular signaling via genetically encoded sensors and FLIM, reducing variability in pathway assessment.
- Strategic Value: Improves go/no-go decisions by linking target engagement to downstream signaling changes in relevant behavioral contexts.
- Portfolio Impact: Facilitates risk-adjusted prioritization of compounds based on their ability to modulate PKA activity in behaving animals, reducing late-stage failure due to lack of target pathway modulation.
Implementation Considerations
- Requires expertise in viral vector delivery or in utero electroporation for neuronal expression of genetically encoded sensors.
- Dependent on two-photon fluorescence lifetime imaging microscopy infrastructure and expertise in FLIM data acquisition and analysis.
- Necessitates standardized protocols for head-fixed preparation, behavioral training, and chronic window maintenance to ensure reproducibility across studies.
- Involves adaptation considerations when applying the method to different brain regions or behavioral assays beyond locomotion.
- Practical limitations include surgical complexity and potential variability in sensor expression levels, which must be controlled for quantitative comparisons.
Biopharma FAQs
Why does null hypothesis testing matter for target validation when visualizing PKA activity?
Null hypothesis testing determines whether observed changes in PKA activity during behavior are statistically significant rather than due to random fluctuation, providing rigorous evidence for target engagement and pathway modulation in preclinical studies.
How does independent variable isolation fit the discovery pipeline for PKA imaging studies?
Isolating independent variables such as specific neuromodulator release or receptor activation allows researchers to attribute changes in PKA activity to defined targets, supporting mechanistic de-risking in early discovery.
What quantitative dependent variable measurements enable PKA activity assessment in behaving mice?
FRET changes measured via two-photon FLIM provide quantitative readouts of PKA activity dynamics, enabling correlation with behavioral states and pharmacological interventions.
Why do replication requirements matter for cross-functional collaboration in PKA imaging workflows?
Replication ensures that PKA activity measurements are consistent across animals, sessions, and laboratories, which is essential for reliable data sharing between discovery, preclinical, and translational teams.
What statistical analysis capabilities are required before implementing PKA FLIM imaging in drug discovery?
Capabilities for analyzing time-series FRET data, comparing distributions across conditions, and modeling relationships between kinase activity and behavior are required to extract meaningful insights from imaging datasets.
Chapters in this video
0:04
Title
1:06
Motorized Treadmill Construction
3:22
In Vivo Two-photon Fluorescence Lifetime Imaging (2pFLIM) Microscopy
6:29
2pFLIM Image Analysis
8:38
Results: Representative 2pFLIM Data Quantification and Targeted A-Kinase Activity-reporter-alpha (t-AKAR-alpha) Tracking
9:29
Conclusion
